University Of Leeds
- Country
- 🇸🇪Sweden
- Ownership
- Private
- Established
- 1904-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.leeds.ac.uk
Clinical Trials
201
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (137 trials with phase data)• Click on a phase to view related trials
Changing Outcomes Through Achievement Emails in COPD Using Routine Healthcare Audits
- Conditions
- COPD (Chronic Obstructive Pulmonary Disease)
- First Posted Date
- 2025-09-18
- Last Posted Date
- 2025-09-18
- Lead Sponsor
- University of Leeds
- Target Recruit Count
- 270
- Registration Number
- NCT07181915
- Locations
- 🇬🇧
NHS West Yorkshire Integrated Care Board, Leeds, United Kingdom
A Study of the Impact of Penicillin Allergy on Antimicrobial Resistance and ouTcomes
- Conditions
- Penicillin AllergyAMRAntimicrobial Drug Resistance
- First Posted Date
- 2025-09-17
- Last Posted Date
- 2025-09-17
- Lead Sponsor
- University of Leeds
- Target Recruit Count
- 214
- Registration Number
- NCT07177690
- Locations
- 🇬🇧
Leeds Teaching Hospitals NHS trust, Leeds, United Kingdom
Nutritional Status and Intake in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB)
- Conditions
- Non Cystic Fibrosis Bronchiectasis
- First Posted Date
- 2025-03-14
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- University of Leeds
- Target Recruit Count
- 129
- Registration Number
- NCT06877091
- Locations
- 🇬🇧
Leeds Teaching Hospitals Trust, Leeds, West Yorkshire, United Kingdom
EORTC Quality of Life Measurement Strategies in Progressive Cancer
- Conditions
- Cancer
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-07-15
- Lead Sponsor
- University of Leeds
- Target Recruit Count
- 20
- Registration Number
- NCT06842654
- Locations
- 🇬🇧
St James Hospital, Leeds, United Kingdom
Heart Failure in Patients With Diabetes: Cells, Crosstalk and Consequences
- Conditions
- Heart FailureHFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionDiabetes Mellitus Type 2
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- University of Leeds
- Target Recruit Count
- 600
- Registration Number
- NCT06774014
- Locations
- 🇬🇧
Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- 39
- Next
News
DANTE Trial Shows Promise for Shorter Immunotherapy Duration in Advanced Melanoma
The UK DANTE phase III trial found that 80.2% of patients who stopped immunotherapy after 12 months maintained disease control, compared to 87.6% who continued treatment for two years or more.
Novel Treatment Regimen Extends Myeloma Remission by Seven Months in UK Clinical Trial
A phase 3 clinical trial led by the University of Leeds demonstrated that a second stem cell transplant followed by ixazomib maintenance therapy extends myeloma remission by seven months compared to standard care.
Reduced-Dose Radiotherapy Shows Promise for Early-Stage Anal Cancer Treatment
The phase 2 PLATO-ACT4 trial demonstrated that reduced-dose intensity-modulated radiotherapy (IMRT) achieved comparable complete clinical response rates to standard dosing in early-stage anal cancer patients.
Panitumumab Plus FOLFOX Significantly Improves Survival in RAS/BRAF Wild-Type Locally Advanced Colon Cancer
Exploratory findings from the FOxTROT trial reveal that adding panitumumab to neoadjuvant FOLFOX chemotherapy significantly reduced recurrence and improved survival in patients with RAS/BRAF wild-type locally advanced colon cancer.
London Biotechnology Show 2025 Returns with Expanded Platform for Industry Innovation and Collaboration
The second annual London Biotechnology Show (#LBS25) builds on the success of its inaugural edition, which attracted over 3,000 attendees from 1,500 companies and featured 70+ sponsors and exhibitors.